Technical Analysis for THRD - Third Harmonic Bio, Inc.

Grade Last Price % Change Price Change
F 4.25 0.00% 0.00
THRD closed unchanged on Thursday, January 26, 2023, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Touch Weakness 0.00%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Mast Cell Immunoglobulin E

Is THRD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 24.59
52 Week Low 3.89
Average Volume 396,829
200-Day Moving Average 0.00
50-Day Moving Average 11.04
20-Day Moving Average 4.29
10-Day Moving Average 4.33
Average True Range 0.57
RSI 24.81
ADX 49.26
+DI 12.74
-DI 37.22
Chandelier Exit (Long, 3 ATRs) 3.13
Chandelier Exit (Short, 3 ATRs) 5.75
Upper Bollinger Bands 4.46
Lower Bollinger Band 4.13
Percent B (%b) 0.38
BandWidth 7.70
MACD Line -1.66
MACD Signal Line -2.17
MACD Histogram 0.5165
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.37
Resistance 3 (R3) 4.37 4.33 4.35
Resistance 2 (R2) 4.33 4.30 4.33 4.34
Resistance 1 (R1) 4.29 4.28 4.29 4.29 4.34
Pivot Point 4.25 4.25 4.25 4.25 4.25
Support 1 (S1) 4.21 4.22 4.21 4.21 4.16
Support 2 (S2) 4.17 4.20 4.17 4.16
Support 3 (S3) 4.13 4.17 4.15
Support 4 (S4) 4.13